Enterprise-Wide License
Showing 253–264 of 286 results
-
Improving Patient Recruitment in Biosimilar Trials
$3,260.00 – $6,520.00 -
Primer: Biosimilars in the US Oncology Market
$880.00 – $1,760.00 -
CRO Quality Benchmarking – Phase I Service Providers (4th Edition)
$4,900.00 – $9,800.00 -
Chronic Obstructive Pulmonary Disease (COPD): Market, Treatment, and Development Overview
$4,900.00 – $9,800.00 -
MSL and Sales Strategies for the US Oncology Market
$4,900.00 – $9,800.00 -
Optimizing Investigator Recruitment in Clinical Trials
$2,460.00 – $4,920.00 -
Optimizing Patient Recruitment in Clinical Trials
$2,460.00 – $4,920.00 -
CRO Quality Benchmarking – Phase II/III Service Providers (4th edition)
$6,800.00 – $13,600.00 -
Optimizing Feasibility in Clinical Trials
$2,460.00 – $4,920.00 -
US Payers: Comparative Effectiveness Research (CER) and Formulary Decision-making
$4,900.00 – $9,800.00 -
Electronic Detailing vs. In-person Detailing (US)
$4,900.00 – $9,800.00 -
Primer: A View of Biosimilars from the Pharmacy
$475.00 – $700.00